Ocugen_August_2021_246_73246
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Ocugen's August 2021 presentation outlines its mission to develop gene therapies for blindness and a COVID-19 vaccine, highlighting future strategies and market potential.
